Clinical trial
Pulmozyme to Improve COVID-19 ARDS Outcomes
NCT04402944 is registered in ClinicalTrials.gov with Boston Children's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pulmozyme to Improve COVID-19 ARDS Outcomes
- Lead sponsor
- Boston Children's Hospital
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- July 5, 2020
- Completion date
- December 31, 2021
- Enrollment
- 60 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
covid